Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-PARK7/DJ1 Antibody (9Q473)
(Synonyms: parkinson protein 7, HEL-S-67p, DJ-1, DJ1) Copy Product Info
🥰Excellent
Synonyms: parkinson protein 7, HEL-S-67p, DJ-1, DJ1
Catalog No. TMAC-03067 Copy Product Info
🥰Excellent
Anti-PARK7/DJ1 Antibody (9Q473) is a Rabbit antibody targeting PARK7/DJ1. Anti-PARK7/DJ1 Antibody (9Q473) can be used in FCM,ICC/IF,IHC,IP,WB.
Anti-PARK7/DJ1 Antibody
(9Q473)
(9Q473)
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 50 μL | $296 | 7-10 days | 7-10 days | |
| 100 μL | $496 | 7-10 days | 7-10 days |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Stability & Storage
| Description | Anti-PARK7/DJ1 Antibody (9Q473) is a Rabbit antibody targeting PARK7/DJ1. Anti-PARK7/DJ1 Antibody (9Q473) can be used in FCM,ICC/IF,IHC,IP,WB. |
| Synonyms | parkinson protein 7, HEL-S-67p, DJ-1, DJ1 |
| Ig Type | IgG |
| Clone | 9Q473 |
| Reactivity | Human,Mouse,Rat |
| Application | |
| Recommended Dose | WB: 1:1000-2000; IHC: 1:100-500; ICC/IF: 1:100-500; FCM: 1:50-100 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | Recombinant Antibody |
| Purification | ProA affinity purified |
| Appearance | Liquid |
| Formulation | 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
| Research Background | PARK7/DJ1 is a ubiquitously expressed protein involved in various cellular processes including cell proliferation, RNA-binding, and oxidative stress. The protein has been found to colocalize within a subset of pathologic tau inclusions in a diverse group of neurodegenerative disorders known as tauopathies. Defects in PARK7/DJ1 are the cause of autosomal recessive early-onset Parkinson's disease 7 (PARK7). Parkinson's disease (PD) is a complex, multifactorial disorder that typically manifests after the age of 50 years. The disease is characterized by bradykinesia, resting tremor, muscular rigidity and postural instability. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. PARK7 is characterized by onset before 40 years and slow progression. It has also been suggested that PARK7/DJ1 is a mitogen dependent oncogene product involved in Ras related signal transduction pathways. |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein |
| Uniprot ID |
| Molecular Weight | Theoretical: 20 kDa. |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
Calculator
Keywords
Preview
Related Tags: Anti-PARK7/DJ1 Antibody (9Q473) molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.